Second and early third trimester pregnancy termination by extra-amniotic balloon and intracervical PGE2

Int J Gynaecol Obstet. 1998 Jan;60(1):29-34. doi: 10.1016/s0020-7292(97)00240-3.

Abstract

Objective: The aim of the study was to investigate the efficacy and safety of an alternative modality using extra-amniotic balloon and intracervical prostaglandin (PG) E2 for termination of second and early third trimester pregnancies.

Method: Thirty-three pregnant women scheduled for legal termination of pregnancy at 15-32 weeks' gestation were included in the study. Each case received extra-amniotic balloon containing 500-800 ml normal saline and two PGE2 tablets inserted into the cervical canal.

Results: All 33 patients achieved a successful termination. The mean induction-to-abortion interval was 12.85 h. There was no significant difference in induction-to-abortion interval between second trimester group and third trimester group. However, the mean duration of balloon distention was longer in the second trimester group. There were no severe complications.

Conclusion: The combined use of extra-amniotic balloon and intracervical PGE2 tablets is effective, safe and convenient for termination of second and early third trimester pregnancy.

Publication types

  • Clinical Trial

MeSH terms

  • Abortion, Legal
  • Abortion, Therapeutic / methods*
  • Adult
  • Amnion
  • Catheterization*
  • Combined Modality Therapy
  • Dinoprostone / administration & dosage*
  • Female
  • Humans
  • Injections, Intralesional
  • Oxytocics / administration & dosage*
  • Pregnancy
  • Pregnancy Trimester, Second
  • Pregnancy Trimester, Third
  • Treatment Outcome

Substances

  • Oxytocics
  • Dinoprostone